Perceived threat of COVID-19, attitudes towards vaccination, and vaccine hesitancy: A prospective longitudinal study in the UK.


Journal

British journal of health psychology
ISSN: 2044-8287
Titre abrégé: Br J Health Psychol
Pays: England
ID NLM: 9605409

Informations de publication

Date de publication:
11 2022
Historique:
revised: 21 04 2022
received: 14 09 2021
accepted: 18 05 2022
pubmed: 2 6 2022
medline: 7 10 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

Using the Health Belief Model as a conceptual framework, we investigated the association between attitudes towards COVID-19, COVID-19 vaccinations, and vaccine hesitancy and change in these variables over a 9-month period in a UK cohort. The COPE study cohort (n = 11,113) was recruited via an online survey at enrolment in March/April 2020. The study was advertised via the HealthWise Wales research registry and social media. Follow-up data were available for 6942 people at 3 months (June/July 2020) and 5037 at 12 months (March/April 2021) post-enrolment. Measures included demographics, perceived threat of COVID-19, perceived control, intention to accept or decline a COVID-19 vaccination, and attitudes towards vaccination. Logistic regression models were fitted cross-sectionally at 3 and 12 months to assess the association between motivational factors and vaccine hesitancy. Longitudinal changes in motivational variables for vaccine-hesitant and non-hesitant groups were examined using mixed-effect analysis of variance models. Fear of COVID-19, perceived susceptibility to COVID-19, and perceived personal control over COVID-19 infection transmission decreased between the 3- and 12-month surveys. Vaccine hesitancy at 12 months was independently associated with low fear of the disease and more negative attitudes towards COVID-19 vaccination. Specific barriers to COVID-19 vaccine uptake included concerns about safety and efficacy in light of its rapid development, mistrust of government and pharmaceutical companies, dislike of coercive policies, and perceived lack of relaxation in COVID-19-related restrictions as the vaccination programme progressed. Decreasing fear of COVID-19, perceived susceptibility to the disease, and perceptions of personal control over reducing infection-transmission may impact future COVID-19 vaccination uptake.

Identifiants

pubmed: 35642867
doi: 10.1111/bjhp.12606
pmc: PMC9347957
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1354-1381

Informations de copyright

© 2022 The Authors. British Journal of Health Psychology published by John Wiley & Sons Ltd on behalf of British Psychological Society.

Références

BMC Public Health. 2022 Jan 15;22(1):104
pubmed: 35033030
J Public Health (Oxf). 2017 Dec 1;39(4):e242-e250
pubmed: 27679662
Health Psychol. 2022 Feb;41(2):85-93
pubmed: 34570535
Isr J Health Policy Res. 2021 May 27;10(1):33
pubmed: 34044891
JAMA. 2020 Aug 25;324(8):732
pubmed: 32840583
Int J Methods Psychiatr Res. 2021 Mar;30(1):e1861
pubmed: 33166018
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
Appl Psychol Health Well Being. 2020 Dec;12(4):1095-1114
pubmed: 32955170
PLoS One. 2021 Oct 13;16(10):e0258484
pubmed: 34644365
BMJ. 2021 Mar 11;372:n699
pubmed: 33707182
Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
Psychol Med. 2020 Dec 11;:1-15
pubmed: 33305716
PLoS One. 2021 Nov 1;16(11):e0248542
pubmed: 34723973
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Nat Hum Behav. 2021 Mar;5(3):337-348
pubmed: 33547453
Health Commun. 2020 Dec;35(14):1718-1722
pubmed: 33124475
Soc Sci Med. 2021 Mar;272:113688
pubmed: 33485215
Emerg Infect Dis. 2004 Aug;10(8):1486-9
pubmed: 15496256
Vaccines (Basel). 2021 May 02;9(5):
pubmed: 34063281
Hum Vaccin Immunother. 2020 Sep 1;16(9):2204-2214
pubmed: 32730103
Aging (Albany NY). 2020 May 29;12(10):9959-9981
pubmed: 32470948
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Lancet Reg Health Eur. 2021 Oct;9:100180
pubmed: 34308406
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
Br J Health Psychol. 2021 Sep;26(3):935-957
pubmed: 33847029
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
PLoS One. 2020 Nov 4;15(11):e0240399
pubmed: 33147219
BMJ Open. 2021 Jun 15;11(6):e048856
pubmed: 34130964
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
Psychol Health Med. 2022 Feb;27(2):379-388
pubmed: 33906540
J Health Commun. 2020 Oct 2;25(10):799-807
pubmed: 33719881
Soc Sci Med. 2020 Nov;265:113414
pubmed: 33038683
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
BMC Public Health. 2021 Apr 26;21(1):804
pubmed: 33902501
Br J Health Psychol. 2021 May;26(2):679-696
pubmed: 33763971
Appl Psychol Health Well Being. 2021 May;13(2):469-484
pubmed: 33634930
Health Educ Q. 1988 Summer;15(2):175-83
pubmed: 3378902
BMJ. 2021 May 10;373:n1185
pubmed: 33972259
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
PLoS One. 2021 Feb 16;16(2):e0239247
pubmed: 33591985
Br J Health Psychol. 2022 Nov;27(4):1354-1381
pubmed: 35642867
BMJ Open. 2019 Dec 2;9(12):e031705
pubmed: 31796481
J Affect Disord. 2010 Apr;122(1-2):86-95
pubmed: 19616305
JAMA Netw Open. 2020 Oct 1;3(10):e2025594
pubmed: 33079199
Front Psychol. 2020 Sep 30;11:551004
pubmed: 33117223
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Front Med (Lausanne). 2021 Jun 04;8:679520
pubmed: 34150811
Glob Public Health. 2020 Dec;15(12):1917-1923
pubmed: 32985374
Ann Behav Med. 2017 Oct;51(5):652-660
pubmed: 28255934
Front Psychol. 2021 Apr 15;12:609893
pubmed: 33935865
Lancet. 2020 Aug 15;396(10249):464-465
pubmed: 32771083
BMJ Open. 2020 Aug 30;10(8):e040448
pubmed: 32868370
BMC Public Health. 2011 Jan 03;11:2
pubmed: 21199571
BMJ. 2021 Mar 9;372:n664
pubmed: 33687925
Emerg Infect Dis. 2007 Feb;13(2):290-3
pubmed: 17479894
J Med Ethics. 2020 Oct;46(10):652-659
pubmed: 32817362
Nature. 2021 Jul;595(7866):161-162
pubmed: 34176923
Vaccines (Basel). 2021 Apr 13;9(4):
pubmed: 33924542
BMJ. 2020 Nov 13;371:m4445
pubmed: 33187961
Br J Health Psychol. 2022 Feb;27(1):13-29
pubmed: 33949038
BMJ Open. 2021 Jun 15;11(6):e048172
pubmed: 34130963
Lancet Infect Dis. 2020 Jul;20(7):769-770
pubmed: 32445713

Auteurs

Rhiannon Phillips (R)

Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University, Cardiff, UK.

David Gillespie (D)

Centre for Trials Research, Cardiff University, Cardiff, UK.

Britt Hallingberg (B)

Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University, Cardiff, UK.

Jennifer Evans (J)

PRIME Centre Wales and Division of Population Medicine, Cardiff University, Cardiff, UK.

Khadijeh Taiyari (K)

PRIME Centre Wales and Division of Population Medicine, Cardiff University, Cardiff, UK.

Anna Torrens-Burton (A)

PRIME Centre Wales and Division of Population Medicine, Cardiff University, Cardiff, UK.

Rebecca Cannings-John (R)

Centre for Trials Research, Cardiff University, Cardiff, UK.

Denitza Williams (D)

Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University, Cardiff, UK.
PRIME Centre Wales and Division of Population Medicine, Cardiff University, Cardiff, UK.

Elizabeth Sheils (E)

Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.

Pauline Ashfield-Watt (P)

HealthWise Wales, Division of Population Medicine, Cardiff University, Cardiff, UK.

Ashley Akbari (A)

Population Data Science, Health Data Research UK, Swansea University Medical School, Swansea University, Swansea, UK.

Kathryn Hughes (K)

PRIME Centre Wales and Division of Population Medicine, Cardiff University, Cardiff, UK.

Emma Thomas-Jones (E)

Centre for Trials Research, Cardiff University, Cardiff, UK.

Delyth James (D)

Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University, Cardiff, UK.

Fiona Wood (F)

PRIME Centre Wales and Division of Population Medicine, Cardiff University, Cardiff, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH